In general, these data indicated that DN T cells attenuated cisplatin-induced AKI by downregulating inflammatory factors of HK-2 cells and possibly upregulating anti-inflammatory factors of HK-2 cells through IL-10/AT2R pathway, which provided evidence for the treatment of cisplatin-induced AKI by inhibiting inflammation. The gene discussed is IL10; the disease is acute kidney injury.